Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters
NCT ID: NCT03134885
Last Updated: 2022-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12989 participants
OBSERVATIONAL
2016-09-30
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
General goals of the post hospitalization monitoring system for suicidal attempters are:
* Standardize general healthcare's practices by offering alert networks and innovative response procedures in case of suicidal crisis.
* Coordinate the various health partners' actions around the patient (GP, psychiatrist, psychologist).
* Contribute to reducing mortality and morbidity by suicide (subsequent suicide) in determined territories.
The evaluation of VigilanS will be quantitative and qualitative.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Message System (SMS) Monitoring Intended for the Suicidal Patients
NCT02106949
Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery
NCT04068584
Usability of SMART ANGEL Medical Device to Record and Transmit Health Data From Patient's Home Following Outpatient Surgery
NCT03464721
Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism
NCT05173116
Out of Hospital Cardiac Arrest: Trial Assessing the Survival Impact of Phone Advice
NCT02934867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phone calls Calling team is composed of 4 psychologists and 3 psychiatric nurses especially trained to detect and manage suicidal crises. Monday to Friday, from 9 AM until 6 PM, there is two callers located in the emergencies' calling center. They will give calls to patients after their entry in the program and they will also receive incoming calls at the number available on "green cards" handed to patients.
Calls 10 days after discharge
Subjects who did at least two suicidal attempts before entering the VigilanS program will be call 10 to 20 days after their discharge from the hospital.
After every call, a short report is sent to the patient psychiatrist or his GP. 6 months calls
For every suicide attempters included in the program, a call is planned at the end of the sixth month after discharge from the hospital. This call aims to make a clinical review of patient and propose the end of the monitoring. If needed, the monitoring program can be reset for a 6 months period. In order to structure the call and gather data on the program evaluation, the six months call includes a psychological assessment by Mini International Neuropsychiatric Interview / MINI DSM V (Sheehan et al. 1998) and by the Columbia Suicide Severity rating Scale C-SSRS (Posner et al. 2011) as well as a global satisfactory survey on the program. If a contacted subject represents a high suicide risk, callers can trigger various actions like in a 10 days call.
If patient is unreachable a unique postcard will be sent to remind him of VigilanS coordinates. After every call, a short report is sent to the patient psychiatrist or his GP.
Postcards After every contact, but mostly after a 10 days call, the caller can decide to send 4 personalized post cards to a patient. One postcard is sent by month on a period of four months. Cards are embodied by patient name, logo of the structure which included him and coordinates of including department.
Quantitative evaluation will assess:
* Profiles of patients with good respond to the program or not (who had or not attempted suicide within 6 months)
* Development of partnership within the program (number of facilities sharing the system, number of patients in the program compared to overall number of suicide attempters addressed to one centre…).
* Program efficiency "in real life" on reduction of suicidal conducts. Using four comparator tools :
* Evolution of suicidal conducts since the implementation of VigilanS in a specific center (comparison "before / after").
* Evolution of suicidal conducts between a region implementing VigilanS and a region which doesn't, upon the same period of time (comparison "here/there").
* Comparison of subsequent suicide attempts rate between patients in VigilanS and patients benefiting of "treatment as usual", within a year.
* Comparison of mortality by suicide rate.
* The impact of VigilanS on a patient's care pathway based on data from CNAMTS' database (National health insurance system).
Qualitative evaluation will assess the system acceptability by patients and professionals and also the variation of representations of suicide by different professionals which are in contact with suicidal patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VigilanS Nord-Pas de Calais cohort
All patients leaving in the Nord-Pas de Calais region and entering in the VigilanS program after a suicide attempt
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* entering in the VigilanS program after a suicide attempt
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regional Agency of Sante Nord Pas-de-Calais
OTHER
Région Nord-Pas de Calais, France
OTHER
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Vaiva, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital, Armentieres
Armentières, , France
General Hospital, Arras
Arras, , France
General Hospital, Bethune
Béthune, , France
General Hospital, Boulogne sur Mer
Boulogne-sur-Mer, , France
General Hospital, Calais
Calais, , France
General Hospital, Cambrai
Cambrai, , France
General Hospital, Denain
Denain, , France
General Hospital, Douai
Douai, , France
General Hospital, Dunkerque
Dunkirk, , France
General Hospital, Fourmies
Fourmies, , France
General Hospital, Hazebrouck
Hazebrouck, , France
Clinic Fleury, Hénin Beaumont
Hénin-Beaumont, , France
Polyclinic, Henin-Beaumont
Hénin-Beaumont, , France
General Hospital, Lens
Lens, , France
Riaumont's Polyclinic, Liévin
Liévin, , France
St Vincent's Hospital, Lille
Lille, , France
University Hospital, Lille
Lille, , France
St Philibert's Hospital, Lomme
Lomme, , France
Genral Hospital, Maubeuge
Maubeuge, , France
General Hospital, Montreuil sur Mer
Montreuil-sur-Mer, , France
General Hospital, Roubaix
Roubaix, , France
Lucien Bonnafé Hospital, Roubaix
Roubaix, , France
General Hospital, St Omer
Saint-Omer, , France
EPSM, St Venant
Saint-Venant, , France
General Hospital, Seclin
Seclin, , France
EPSM, Tourcoing
Tourcoing, , France
General Hospital, Tourcoing
Tourcoing, , France
General Hospital, Valenciennes
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Demesmaeker A, Creupelandt C, Leroy A, Vaiva G, D'Hondt F. Impact of posttraumatic stress disorder and comorbid psychiatric conditions on suicide reattempts. Eur J Psychotraumatol. 2025 Dec;16(1):2461435. doi: 10.1080/20008066.2025.2461435. Epub 2025 Feb 12.
Demesmaeker A, Amad A, Chazard E, Demarty AL, Schlienger H, Lehmann E, Debien C, Jardon V, Bounebache K, Rey G, Vaiva G. Suicide and All-Cause Mortality Within 1 Year After a Suicide Attempt in the VigilanS Cohort. J Clin Psychiatry. 2023 Sep 11;84(6):22m14520. doi: 10.4088/JCP.22m14520.
Fossi LD, Debien C, Demarty AL, Vaiva G, Messiah A. Suicide reattempt in a population-wide brief contact intervention to prevent suicide attempts: The VigilanS program, France. Eur Psychiatry. 2021 Jul 16;64(1):e57. doi: 10.1192/j.eurpsy.2021.2221.
Duhem S, Berrouiguet S, Debien C, Ducrocq F, Demarty AL, Messiah A, Courtet P, Jehel L, Thomas P, Deplanque D, Danel T, Walter M, Notredame CE, Vaiva G. Combining brief contact interventions (BCI) into a decision-making algorithm to reduce suicide reattempt: the VigilanS study protocol. BMJ Open. 2018 Oct 23;8(10):e022762. doi: 10.1136/bmjopen-2018-022762.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01984-45
Identifier Type: OTHER
Identifier Source: secondary_id
2015_52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.